IBDEI1EZ ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25354,2)
 ;;=Hx of Tobacco Use (not current)^303405
 ;;^UTILITY(U,$J,358.3,25355,0)
 ;;=V12.01^^145^1538^54
 ;;^UTILITY(U,$J,358.3,25355,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25355,1,4,0)
 ;;=4^V12.01
 ;;^UTILITY(U,$J,358.3,25355,1,5,0)
 ;;=5^Hx of TB
 ;;^UTILITY(U,$J,358.3,25355,2)
 ;;=Hx of TB^303393
 ;;^UTILITY(U,$J,358.3,25356,0)
 ;;=V13.01^^145^1538^36
 ;;^UTILITY(U,$J,358.3,25356,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25356,1,4,0)
 ;;=4^V13.01
 ;;^UTILITY(U,$J,358.3,25356,1,5,0)
 ;;=5^Hx of Kidney Stones
 ;;^UTILITY(U,$J,358.3,25356,2)
 ;;=Hx of Kidney Stones^303403
 ;;^UTILITY(U,$J,358.3,25357,0)
 ;;=V12.51^^145^1538^59
 ;;^UTILITY(U,$J,358.3,25357,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25357,1,4,0)
 ;;=4^V12.51
 ;;^UTILITY(U,$J,358.3,25357,1,5,0)
 ;;=5^Hx of Venous Thrombosis And Embolism
 ;;^UTILITY(U,$J,358.3,25357,2)
 ;;=^303397
 ;;^UTILITY(U,$J,358.3,25358,0)
 ;;=V17.89^^145^1538^18
 ;;^UTILITY(U,$J,358.3,25358,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25358,1,4,0)
 ;;=4^V17.89
 ;;^UTILITY(U,$J,358.3,25358,1,5,0)
 ;;=5^Family h/o Musculosk Disease
 ;;^UTILITY(U,$J,358.3,25358,2)
 ;;=^332861
 ;;^UTILITY(U,$J,358.3,25359,0)
 ;;=V12.54^^145^1538^56
 ;;^UTILITY(U,$J,358.3,25359,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25359,1,4,0)
 ;;=4^V12.54
 ;;^UTILITY(U,$J,358.3,25359,1,5,0)
 ;;=5^Hx of TIA
 ;;^UTILITY(U,$J,358.3,25359,2)
 ;;=^335309
 ;;^UTILITY(U,$J,358.3,25360,0)
 ;;=V12.54^^145^1538^52
 ;;^UTILITY(U,$J,358.3,25360,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25360,1,4,0)
 ;;=4^V12.54
 ;;^UTILITY(U,$J,358.3,25360,1,5,0)
 ;;=5^Hx of Stroke w/o Residual
 ;;^UTILITY(U,$J,358.3,25360,2)
 ;;=^335309
 ;;^UTILITY(U,$J,358.3,25361,0)
 ;;=V15.88^^145^1538^33
 ;;^UTILITY(U,$J,358.3,25361,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25361,1,4,0)
 ;;=4^V15.88
 ;;^UTILITY(U,$J,358.3,25361,1,5,0)
 ;;=5^Hx of Fall(s)
 ;;^UTILITY(U,$J,358.3,25361,2)
 ;;=^332859
 ;;^UTILITY(U,$J,358.3,25362,0)
 ;;=V13.59^^145^1538^42
 ;;^UTILITY(U,$J,358.3,25362,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25362,1,4,0)
 ;;=4^V13.59
 ;;^UTILITY(U,$J,358.3,25362,1,5,0)
 ;;=5^Hx of Musculosk Disease
 ;;^UTILITY(U,$J,358.3,25362,2)
 ;;=^295268
 ;;^UTILITY(U,$J,358.3,25363,0)
 ;;=V15.52^^145^1538^55
 ;;^UTILITY(U,$J,358.3,25363,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25363,1,4,0)
 ;;=4^V15.52
 ;;^UTILITY(U,$J,358.3,25363,1,5,0)
 ;;=5^Hx of TBI
 ;;^UTILITY(U,$J,358.3,25363,2)
 ;;=^338495
 ;;^UTILITY(U,$J,358.3,25364,0)
 ;;=V12.04^^145^1538^38
 ;;^UTILITY(U,$J,358.3,25364,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25364,1,4,0)
 ;;=4^V12.04
 ;;^UTILITY(U,$J,358.3,25364,1,5,0)
 ;;=5^Hx of MRSA Infection
 ;;^UTILITY(U,$J,358.3,25364,2)
 ;;=^336780
 ;;^UTILITY(U,$J,358.3,25365,0)
 ;;=V13.51^^145^1538^23
 ;;^UTILITY(U,$J,358.3,25365,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25365,1,4,0)
 ;;=4^V13.51
 ;;^UTILITY(U,$J,358.3,25365,1,5,0)
 ;;=5^Hs of Pathological Fx
 ;;^UTILITY(U,$J,358.3,25365,2)
 ;;=^336781
 ;;^UTILITY(U,$J,358.3,25366,0)
 ;;=V15.51^^145^1538^58
 ;;^UTILITY(U,$J,358.3,25366,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25366,1,4,0)
 ;;=4^V15.51
 ;;^UTILITY(U,$J,358.3,25366,1,5,0)
 ;;=5^Hx of Traumatic Fx
 ;;^UTILITY(U,$J,358.3,25366,2)
 ;;=^336786
 ;;^UTILITY(U,$J,358.3,25367,0)
 ;;=V62.22^^145^1538^49
 ;;^UTILITY(U,$J,358.3,25367,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25367,1,4,0)
 ;;=4^V62.22
 ;;^UTILITY(U,$J,358.3,25367,1,5,0)
 ;;=5^Hx of Return from Military Deployment
 ;;^UTILITY(U,$J,358.3,25367,2)
 ;;=^336807
 ;;^UTILITY(U,$J,358.3,25368,0)
 ;;=919.1^^145^1539^1
